Metraipolis › archive › dc_93b1bf0996fe

Efficacy and Toxicity in Scheduled Intravesical Gemcitabine Versus Bacillus Calmette-Guérin for Bladder Cancer: A Systematic Review and Meta-Analysis — Europe PMC PMID:41899592

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41899592
DOI
10.3390/cancers18060990
License (as archived)
solo-consultazione
Archived
2026-11-04T06:38:53.772Z
SHA-256 of the archived text
677bde4a50338c279cf27706aa3d6fbab8686ef5515a7e9b900ca9b584ea8428
Stable URL of this page
https://metraipolis.com/documento/dc_93b1bf0996fe

How to cite

Efficacy and Toxicity in Scheduled Intravesical Gemcitabine Versus Bacillus Calmette-Guérin for Bladder Cancer: A Systematic Review and Meta-Analysis — Europe PMC PMID:41899592 — Europe PMC (en), https://europepmc.org/article/MED/41899592 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_93b1bf0996fe (Metraipolis archive dc_93b1bf0996fe, sha256 677bde4a50338c279cf27706aa3d6fbab8686ef5515a7e9b900ca9b584ea8428)
BibTeX
@misc{dc93b1bf0996fe,
  title = {Efficacy and Toxicity in Scheduled Intravesical Gemcitabine Versus Bacillus Calmette-Guérin for Bladder Cancer: A Systematic Review and Meta-Analysis — Europe PMC PMID:41899592},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41899592},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_93b1bf0996fe; sha256 677bde4a50338c279cf27706aa3d6fbab8686ef5515a7e9b900ca9b584ea8428},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41899592. Agents can read the archived copy with the MCP tool read_document.